These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 507883

  • 1. Management of necrotizing vasculitis with colchicine. Improvement in patients with cutaneous lesions and Behcet's syndrome.
    Hazen PG, Michel B.
    Arch Dermatol; 1979 Nov; 115(11):1303-6. PubMed ID: 507883
    [Abstract] [Full Text] [Related]

  • 2. Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial.
    Sais G, Vidaller A, Jucglà A, Gallardo F, Peyrí J.
    Arch Dermatol; 1995 Dec; 131(12):1399-402. PubMed ID: 7492128
    [Abstract] [Full Text] [Related]

  • 3. Urticarial vasculitis treated with colchicine.
    Wiles JC, Hansen RC, Lynch PJ.
    Arch Dermatol; 1985 Jun; 121(6):802-5. PubMed ID: 4004306
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Behçet's disease with relapsing cutaneous polyarteritis-nodosa-like lesions, responsive to oral cyclosporine therapy.
    Vikas A, Atul S, Singh R, Sarbmeet L, Mohan H.
    Dermatol Online J; 2003 Dec; 9(5):9. PubMed ID: 14996382
    [Abstract] [Full Text] [Related]

  • 6. A histopathological approach: when papulopustular lesions should be in the diagnostic criteria of Behçet's disease?
    Kalkan G, Karadag AS, Astarci HM, Akbay G, Ustun H, Eksioglu M.
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1056-60. PubMed ID: 19453803
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of Behçet's syndrome with colchicine].
    Pacor ML, Nicolis F, Peroli P, Urbani G, Cortina P, Corrocher R, Lunardi C.
    Riv Eur Sci Med Farmacol; 1989 Jun; 11(3):257-61. PubMed ID: 2640046
    [Abstract] [Full Text] [Related]

  • 8. [Pustular vasculitis disclosing Behçet disease].
    Castanet J, Carmignani S, Lacour JP, Perrin C, Lagrange B, Dor JF, Ortonne JP.
    Ann Dermatol Venereol; 1994 Jun; 121(9):629-31. PubMed ID: 7771731
    [Abstract] [Full Text] [Related]

  • 9. [Therapeutic value of colchicine in Behçhet's disease (author's transl)].
    Moreno Moraga J, Estrada Saiz RV, Chantres Antoranz MT, Rivas Flores J, Gilsanz García V.
    Med Clin (Barc); 1981 Jun 10; 77(1):18-20. PubMed ID: 6454812
    [Abstract] [Full Text] [Related]

  • 10. Behçet's syndrome treated with colchicine.
    de Bois MH, Geelhoed-Duijvestijn PH, Westedt ML.
    Neth J Med; 1991 Apr 10; 38(3-4):175-6. PubMed ID: 1881506
    [No Abstract] [Full Text] [Related]

  • 11. Colchicine revisited.
    Bhat A, Naguwa SM, Cheema GS, Gershwin ME.
    Ann N Y Acad Sci; 2009 Sep 10; 1173():766-73. PubMed ID: 19758227
    [Abstract] [Full Text] [Related]

  • 12. [Behcet's disease. Trial treatment with colchicine].
    Bennouna-Biaz F, Heid E, Lazrak B.
    Ann Dermatol Venereol; 1982 Sep 10; 109(6-7):593-4. PubMed ID: 7187187
    [No Abstract] [Full Text] [Related]

  • 13. [A case of Behçet's disease associated with neuromyopathy induced by combination therapy with colchicine and cyclosporin].
    Fujii Y, Arimura Y, Takahashi N, Toki T, Marumo T, Yoshihara K, Nakabayashi K, Yamada A.
    Ryumachi; 2003 Feb 10; 43(1):44-50. PubMed ID: 12692989
    [Abstract] [Full Text] [Related]

  • 14. Behçet's syndrome: immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy.
    Jorizzo JL, Hudson RD, Schmalstieg FC, Daniels JC, Apisarnthanarax P, Henry JC, Gonzalez EB, Ichikawa Y, Cavallo T.
    J Am Acad Dermatol; 1984 Feb 10; 10(2 Pt 1):205-14. PubMed ID: 6371066
    [Abstract] [Full Text] [Related]

  • 15. Behçet's disease with unusual cutaneous lesions.
    Aydin F, Senturk N, Yildiz L, Canturk MT, Turanli AY.
    J Eur Acad Dermatol Venereol; 2006 Jan 10; 20(1):106-7. PubMed ID: 16405624
    [No Abstract] [Full Text] [Related]

  • 16. Investigation of ABCB1 gene polymorphism with colchicine response in Behçet's disease.
    Saricaoglu H, Yilmaz M, Karkucak M, Ozturk HZ, Yakut T, Gulten T, Baskan EB, Aydogan K, Dilek K.
    Genet Mol Res; 2011 Jan 04; 10(1):1-6. PubMed ID: 21218380
    [Abstract] [Full Text] [Related]

  • 17. [Renal amyloidosis during Behçet's disease. Study of one case].
    Azzabi S, Ben Hassine L, Cherif E, Kooli C, Kaouache Z, Goucha R, Khedher A, Ben Moussa F, Khalfallah N.
    Tunis Med; 2009 Mar 04; 87(3):213-4. PubMed ID: 19537018
    [Abstract] [Full Text] [Related]

  • 18. Major arterial involvement and review of Behcet's disease.
    Alpagut U, Ugurlucan M, Dayioglu E.
    Ann Vasc Surg; 2007 Mar 04; 21(2):232-9. PubMed ID: 17349371
    [Abstract] [Full Text] [Related]

  • 19. Thalidomide effects in Behçet's syndrome and pustular vasculitis.
    Jorizzo JL, Schmalstieg FC, Solomon AR, Cavallo T, Taylor RS, Rudloff HB, Schmalstieg EJ, Daniels JC.
    Arch Intern Med; 1986 May 04; 146(5):878-81. PubMed ID: 3963978
    [Abstract] [Full Text] [Related]

  • 20. Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis.
    Callen JP.
    J Am Acad Dermatol; 1985 Aug 04; 13(2 Pt 1):193-200. PubMed ID: 4044947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.